Maksim A. Sokolovskii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maksim A. Sokolovskii has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Aleksei S. Timofeev
Ural State Medical University
1 shared publication - Alfia I. Zagidullina
Krasnousolsky Central District Hospital
1 shared publication - Alvina I. Semenova
The Russian National Research Medical University named after N.I. Pirogov
1 shared publication - Anait A. Arutynyan
Rostov State Medical University
1 shared publication - Anastasiya A. Khritova
Pirogov Russian National Research Medical University, Ostrovityanova 1, 117997 Moscow, Russia
1 shared publication - Andrey Viktorovich Chaplin
Pirogov Russian National Research Medical University, Ostrovityanova 1, 117997 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
Enterococcus Phage Abitsa: Biological Characterization, Antibiofilm Activity and Evolutionary Insights into the Genus Efquatrovirus
Enterococcus faecalis is an important opportunistic pathogen associated with persistent oral infections, biofilm formation, and antimicrobial tolerance, which makes phages targeting this species of both therapeutic and evolutionary interest. Here, we describe the isolation and characterization of Abitsa, a novel lytic Enterococcus phage representing a new species within the genus Efquatrovirus. Abitsa formed small plaques and displayed siphovirus-like morphology. It showed an optimal multiplicity of infection of 0.01, a short latent period of 10 min and a burst size of 28 ± 5 virions per infected cell. The phage efficiently suppressed planktonic growth of E. faecalis over a broad multiplicity of infection (MOI) range and significantly disrupted pre-formed biofilms, with the strongest effect observed at MOI 0.1, resulting in an 82.14% reduction in biofilm biomass. Abitsa remained stable at pH 4–8, at 5–50 °C for 1 h, and in up to 75% chloroform, but exhibited a narrow host range, lysing only one additional clinical E. faecalis isolate among 34 tested enterococcal isolates. Genome analysis showed that Abitsa has a 41,581-bp linear genome lacking lysogeny-associated genes and represents a novel Efquatrovirus species. Comparative structural and phylogenetic analyses additionally supported mosaic evolution and extensive domain shuffling in receptor-binding and lysis-related proteins of Efquatrovirus-like phages. Together, these results identify Abitsa as a biologically unusual and evolutionarily informative lytic phage with antibiofilm activity.
Open AccessEnterococcus Phage Abitsa: Biological Characterization, Antibiofilm Activity and Evolutionary Insights into the Genus Efquatrovirus
Enterococcus faecalis is an important opportunistic pathogen associated with persistent oral infections, biofilm formation, and antimicrobial tolerance, which makes phages targeting this species of both therapeutic and evolutionary interest. Here, we describe the isolation and characterization of Abitsa, a novel lytic Enterococcus phage representing a new species within the genus Efquatrovirus. Abitsa formed small plaques and displayed siphovirus-like morphology. It showed an optimal multiplicity of infection of 0.01, a short latent period of 10 min and a burst size of 28 ± 5 virions per infected cell. The phage efficiently suppressed planktonic growth of E. faecalis over a broad multiplicity of infection (MOI) range and significantly disrupted pre-formed biofilms, with the strongest effect observed at MOI 0.1, resulting in an 82.14% reduction in biofilm biomass. Abitsa remained stable at pH 4–8, at 5–50 °C for 1 h, and in up to 75% chloroform, but exhibited a narrow host range, lysing only one additional clinical E. faecalis isolate among 34 tested enterococcal isolates. Genome analysis showed that Abitsa has a 41,581-bp linear genome lacking lysogeny-associated genes and represents a novel Efquatrovirus species. Comparative structural and phylogenetic analyses additionally supported mosaic evolution and extensive domain shuffling in receptor-binding and lysis-related proteins of Efquatrovirus-like phages. Together, these results identify Abitsa as a biologically unusual and evolutionarily informative lytic phage with antibiofilm activity.
- 27 October 2025
- Published by ECO-Vector LLC (Publications) in Russian Journal of Forensic Medicine
- Vol. 11 (3) , 276-288
Innovative strategies for estimating the postmortem interval in forensic practice: multiomics, artificial intelligence, and hybrid models (a review)
Determination of the postmortem interval remains one of the key tasks in forensic practice, as the accuracy of this assessment directly affects the objectivity of expert conclusions and the effectiveness of investigative procedures. Traditional postmortem interval estimation methods based on morphological indicators and thermometry have limited reliability, especially in the late postmortem period. Current research focuses on developing innovative approaches employing molecular technologies, microbiome analysis, multiomic strategies, and the integration of artificial intelligence for large-scale data processing. This review summarizes modern methods for estimating the postmortem interval, including nucleic acid (DNA and RNA) analysis, proteomic and metabolomic approaches, and the study of microbiome changes. Particular attention is given to immunohistochemical markers, mass spectrometry, and nuclear magnetic resonance for quantification of biochemical processes in tissues and biological fluids. The prospects of applying molecular and chemical methods in forensic entomology during the late postmortem period are highlighted. A separate section discusses the use of machine and deep learning algorithms to construct predictive models based on multimodal data, including microbiome profiles, imaging features, and environmental parameters. Examples of combined approaches integrating biomolecular markers and computational technologies are presented, enabling more accurate estimation of the postmortem interval during both early and late postmortem periods.
- 27 October 2025
- Published by ECO-Vector LLC (Publications) in Russian Journal of Forensic Medicine
- Vol. 11 (3) , 276-288
Innovative strategies for estimating the postmortem interval in forensic practice: multiomics, artificial intelligence, and hybrid models (a review)
Determination of the postmortem interval remains one of the key tasks in forensic practice, as the accuracy of this assessment directly affects the objectivity of expert conclusions and the effectiveness of investigative procedures. Traditional postmortem interval estimation methods based on morphological indicators and thermometry have limited reliability, especially in the late postmortem period. Current research focuses on developing innovative approaches employing molecular technologies, microbiome analysis, multiomic strategies, and the integration of artificial intelligence for large-scale data processing. This review summarizes modern methods for estimating the postmortem interval, including nucleic acid (DNA and RNA) analysis, proteomic and metabolomic approaches, and the study of microbiome changes. Particular attention is given to immunohistochemical markers, mass spectrometry, and nuclear magnetic resonance for quantification of biochemical processes in tissues and biological fluids. The prospects of applying molecular and chemical methods in forensic entomology during the late postmortem period are highlighted. A separate section discusses the use of machine and deep learning algorithms to construct predictive models based on multimodal data, including microbiome profiles, imaging features, and environmental parameters. Examples of combined approaches integrating biomolecular markers and computational technologies are presented, enabling more accurate estimation of the postmortem interval during both early and late postmortem periods.
- 6 August 2025
- Published by ECO-Vector LLC in Urology Reports (St. - Petersburg)
- Vol. 15 (2) , 203-216
Current State of Integration of ERAS Principles into Radical Prostatectomy Practice for Prostate Cancer
The Enhanced Recovery After Surgery (ERAS) concept is a comprehensive multidisciplinary approach based on scientific principles, aimed at optimizing patient management during the perioperative period. Despite the proven efficacy of ERAS across various oncological surgeries, the impact of this approach on perioperative outcomes in the treatment of prostate cancer remains underexplored. This review analyzes current scientific data on the application of ERAS principles in the preoperative, intraoperative, and postoperative stages of prostate cancer treatment. A literature search was conducted in the electronic databases PubMed and Google Scholar using the following keywords in Russian and English: концепция ускоренного восстановления после операции / enhanced recovery after surgery, радикальная простатэктомия / radical prostatectomy, роботическая радикальная простатэктомия / robotic radical prostatectomy, рак предстательной железы / prostate cancer, and eras. The search was performed in accordance with PRISMA guidelines. A total of 100 studies were included in the review. ERAS encompasses the entire perioperative period, from patient preparation to postoperative recovery. This enables effective implementation of radical prostatectomy and ensures high-quality rehabilitation. Currently, the combination of ERAS with robotic radical prostatectomy demonstrates advantages related to minimal invasiveness and high procedural reliability, which contribute to shorter operative times, reduced postoperative complications, accelerated patient’s recovery, and improved healthcare staff satisfaction. To fully assess the benefits of ERAS, it is essential to systematize existing concepts and recommendations in the field of surgical treatment of prostate cancer and to conduct high-quality multicenter studies aimed at exploring rehabilitation, complication prevention, and patient-reported outcomes. This will help expand the potential of ERAS and enhance its impact on treatment outcomes.
- 6 August 2025
- Published by ECO-Vector LLC in Urology Reports (St. - Petersburg)
- Vol. 15 (2) , 203-216
Current State of Integration of ERAS Principles into Radical Prostatectomy Practice for Prostate Cancer
The Enhanced Recovery After Surgery (ERAS) concept is a comprehensive multidisciplinary approach based on scientific principles, aimed at optimizing patient management during the perioperative period. Despite the proven efficacy of ERAS across various oncological surgeries, the impact of this approach on perioperative outcomes in the treatment of prostate cancer remains underexplored. This review analyzes current scientific data on the application of ERAS principles in the preoperative, intraoperative, and postoperative stages of prostate cancer treatment. A literature search was conducted in the electronic databases PubMed and Google Scholar using the following keywords in Russian and English: концепция ускоренного восстановления после операции / enhanced recovery after surgery, радикальная простатэктомия / radical prostatectomy, роботическая радикальная простатэктомия / robotic radical prostatectomy, рак предстательной железы / prostate cancer, and eras. The search was performed in accordance with PRISMA guidelines. A total of 100 studies were included in the review. ERAS encompasses the entire perioperative period, from patient preparation to postoperative recovery. This enables effective implementation of radical prostatectomy and ensures high-quality rehabilitation. Currently, the combination of ERAS with robotic radical prostatectomy demonstrates advantages related to minimal invasiveness and high procedural reliability, which contribute to shorter operative times, reduced postoperative complications, accelerated patient’s recovery, and improved healthcare staff satisfaction. To fully assess the benefits of ERAS, it is essential to systematize existing concepts and recommendations in the field of surgical treatment of prostate cancer and to conduct high-quality multicenter studies aimed at exploring rehabilitation, complication prevention, and patient-reported outcomes. This will help expand the potential of ERAS and enhance its impact on treatment outcomes.